<DOC>
	<DOCNO>NCT01262690</DOCNO>
	<brief_summary>This study examine whether single dose PF-05230901 safe well tolerate give healthy volunteer injection skin . An additional objective measure blood concentration PF-05230901 . Each dose test different group subject start low dose .</brief_summary>
	<brief_title>A Study In Healthy Subjects Of Single Doses PF-05230901 Injected Under The Skin</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<criteria>Healthy subject History seizure , include childhood seizure . History movement disorder related neurological condition . History head trauma associate loss consciousness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>First-in-human ( FIH )</keyword>
	<keyword>Single Ascending Dose ( SAD ) Study</keyword>
	<keyword>TAM-163</keyword>
	<keyword>PF-05230901</keyword>
	<keyword>Cachexia</keyword>
</DOC>